Half-year report · Q2
4569.TEDINET S100UQJL
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥55.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥119.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.8bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.5bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥178.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥177.6bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥176.1bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥48.8bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥46.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥130.0bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥130.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥126.2bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥5.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥327m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥21.86 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.41 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.97 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 72.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 440
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | CurrentYTDDuration | -215000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 327000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -5235000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | -10000000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 14000000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -100000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -100000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -1853000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -1855000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -66000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -57000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -2020000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 1987000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 95000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -0 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 6767000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 130000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 18816000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 13886000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 25584000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 14017000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 1495000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 1478000000 | JPY |
| Payrolls and allowances sga | Prior1YTDDuration | 4407000000 | JPY |
| Payrolls and allowances sga | CurrentYTDDuration | 4415000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 581000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 497000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 3842000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 3844000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-13 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第67期中（自 2024年４月１日 至 2024年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)杏林製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | KYORIN Pharmaceutical Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 荻原 豊 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目３番７号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6374-9700（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理財務部長 番場 作郎 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目３番７号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6374-9704 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経理財務部長 番場 作郎 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00985 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45690 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)杏林製薬株式会社 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |